⌘K

Home/Filings/4/0001496259-12-000004

4//SEC Filing

Deschenes Roger P. 4

Accession 0001496259-12-000004

CIK 0001068874other

View on SEC.gov Company Profile

Filed

Nov 20, 7:00 PM ET

Accepted

Nov 21, 1:17 PM ET

Size

10.5 KB

Accession

0001496259-12-000004

Insider Transaction Report

Form 4

Period: 2012-11-20

IMPLANT SCIENCES CORPOTCBB:IMSC

Deschenes Roger P.

Chief Financial Officer

Transactions

Exercise/Conversion
Common Stock
2012-11-20$0.17/sh+75,000$12,750→ 100,000 total
Exercise/Conversion
Stock Option (Right to Buy)
2012-11-20+25,000→ 0 total
Exercise: $0.20Exp: 2013-12-30→ Common Stock (25,000 underlying)
Exercise/Conversion
Common Stock
2012-11-20$0.20/sh+25,000$5,000→ 25,000 total
Exercise/Conversion
Stock Option (Right to Buy)
2012-11-20+75,000→ 0 total
Exercise: $0.17Exp: 2014-02-05→ Common Stock (75,000 underlying)

Footnotes (2)

[F1]These options are exercisable as to 4,196 shares on December 30, 2008, another 10,402 shares on December 30, 2009 with the remaining 10,402 shares exercisable on December 30, 2010.
[F2]These options are exercisable in three equal annual installments of 25,000 shares commencing February 5, 2009.

Documents

1 file

4
primary_doc.xmlPrimary
PRIMARY DOCUMENT

Issuer

IMPLANT SCIENCES CORP

CIK 0001068874

Entity typeother

Related Parties

1

filerCIK 0001496259

Filing Metadata

Form type: 4
Filed: Nov 20, 7:00 PM ET
Accepted: Nov 21, 1:17 PM ET
Size: 10.5 KB

View on SEC.gov